gov ie - Statement from Acting Chief Medical Officer Dr Ronan Glynn gov.ie - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gov.ie Daily Mail and Mail on Sunday newspapers.
The European Medicines Agency concluded yesterday that CVST, as well splanchnic vein thrombosis - a blood clot in the abdomen - should be listed as very rare side effects of AstraZeneca s vaccine.
The Irish Times says the woman is in recovery and is expected to be discharged from the Mater in the next few days.
This is after she spent one week in a stroke ward at the hospital.
Dr Lorraine Nolan, chief executive of the HPRA, said at Thursday s Department of Health briefing: Today, we received into our database one case report of what we would term a case of special interest and that s because it describes a CVST.
Updated: 8 Apr 2021, 20:51
MICHEAL Martin hailed the delivery of Ireland’s one millionth vaccine, as he promised: “Brighter days are coming.”
The milestone was confirmed by the HSE, as it promised to issue between 180,000 and 190,000 doses next week.
6
6
Some 19 per cent of the population have received their first dose and eight per cent have received both jabsCredit: PA
6
6
6
Three kidney transplant teens have shared their joy in getting the jab after cocooning for months
Around three quarters of the one million were Pfizer/Biontech, while a fifth were AstraZeneca and between four and five per cent were Moderna.
Reid said 19 per cent of the population have received their first dose and eight per cent have received both jabs.
Updated: 8 Apr 2021, 19:26
THE first Irish case of a rare blood clot in a person who has received the AstraZeneca Covid-19 vaccine is being investigated.
NPHET and health chiefs have reminded anyone receiving the vaccine to be aware of the symptoms of the rare clot.
2
2
The woman is said to be recovering in hospitalCredit: Reuters
The woman with the reported rare clot is 40-years-old, from Dublin and receiving treatment at the Mater Hospital, according to the Irish Times.
Speaking at a health briefing, the Health Products Regulatory Authority s Dr Lorraine Nolan said: Today we received into our database one case of what we would call a case of special interest.